Flagship debuts AI biotech startup Expedition with $50Mnews2025-10-22T10:30:19+00:00October 22nd, 2025|Endpoints News|
Chemify raises $50M+ Series B to scale molecule-making businessnews2025-10-21T12:00:17+00:00October 21st, 2025|Endpoints News|
Interview with Anthropic’s life sciences head on AI in bio productnews2025-10-20T10:00:16+00:00October 20th, 2025|Endpoints News|
Lila Sciences closes $350M Series A, bringing in Nvidianews2025-10-14T13:41:42+00:00October 14th, 2025|Endpoints News|
Bristol Myers, insitro extend ALS drug research dealnews2025-10-14T11:00:40+00:00October 14th, 2025|Endpoints News|
Takeda, Nabla Bio sign second research deal for AI-made proteinsnews2025-10-14T09:00:52+00:00October 14th, 2025|Endpoints News|
In the Lab: How Amgen sees AI changing pharma R&Dnews2025-10-08T14:00:50+00:00October 8th, 2025|Endpoints News|
Post-Hoc Live: Vijay Pande talks AI bio, starting new fund VZVC after a16znews2025-10-07T11:00:09+00:00October 7th, 2025|Endpoints News|
Epic embraces the newfound attention of its AI toolsnews2025-09-25T13:00:26+00:00September 25th, 2025|Endpoints News|
Endpoints 11 winner 2025: Chai Discovery aims to design drugs on the computernews2025-09-19T14:00:57+00:00September 19th, 2025|Endpoints News|
